Highland Capital Management »

Sarepta Therapeutics shares owned by Highland Capital Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Highland Capital Management from 13F filings

Historical chart of Highland Capital Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Highland Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Highland Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 46k 21.76
2020-09-30 $1.8M 13k 140.41
2020-06-30 $2.0M 12k 160.30

More positions owned by Highland Capital Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
iShares S&P 500 Index (IVV)
Amazon (AMZN)
Alphabet Inc Class C cs (GOOG)
Costco Wholesale Corporation (COST)
Goldman Sachs (GS)
Merck & Co (MRK)
Facebook Inc cl a (META)
Citigroup (C)

View all positions for Highland Capital Management

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
Vanguard Portfolio Management
State Street Corporation
AQR Capital Management
Two Sigma Investments
Vanguard Capital Management
First Trust Advisors
RA Capital Management
Susquehanna International
Erste Asset Management GmbH
Morgan Stanley
Standard Life Aberdeen
Citadel Advisors
UBS Group

View all funds holding Sarepta Therapeutics